Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Minntech investigating Biocor oxygenator blood pressure drops; firm advises customers to suspend use.

This article was originally published in The Gray Sheet

Executive Summary

MINNTECH INVESTIGATION INTO BIOCOR OXYGENATOR BLOOD PRESSURE DROPS should shed light on the cause of the problem within three to four weeks, the firm states. Minntech sent a letter to its international distributors for the device on June 27 asking them to tell customers to stop using the oxygenator due to "reports of unexplained high pressure drops" during cardiopulmonary bypass procedures. The company is drafting another letter to perfusionists that it expects to send early in the week of July 1.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT006280

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel